Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

CSE/VEXT stock hub

CSE/VEXT has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CSE/VEXTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

81.6M

Canadian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CSE/VEXT

In the news

Latest news · CSE/VEXT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROE-27.4

P25 -121.5P50 -40.9P75 0.5

ROIC-7.5

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CSE/VEXT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

188

Groups with data

Currency

USD

Showing 188 of 188 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 122.7M
Exchange	Canadian Securities Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CA9255401064
Last refreshed	2026-05-10
Market cap	CAD 81.6M
Price	CAD 0.33
Price currency	CAD
Sector	Healthcare
Sic	2834
Symbol	cse/VEXT
Website	https://www.vextscience.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-30.24%
EV Earnings	-4.97x
EV/EBITDA	10.01x
EV/FCF	10.98x
EV/Sales	1.74x
FCF yield	13.69%
P/B ratio	1.07x
P/S ratio	1.16x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-13.51%
EBITDA Margin	17.4%
FCF margin	15.86%
Gross margin	28.14%
Gross Profit	CAD 19.8M
Gross Profit Growth	61%
Gross Profit Growth Q	56.04%
Gross Profit Growth3 Y	-14.46%
Gross Profit Growth5 Y	6.09%
Net Income	CAD -24.7M
Net Income Growth Years	1%
Pretax Margin	-29.62%
Profit Margin	-35.03%
ROA	-3.37
Roa5y	0.16
ROCE	-7.54
ROE	-27.45
Roe5y	-4.28
ROIC	-7.5
Roic5y	-0.51

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	200.23%
Cagr3y	3.81%
Cagr5y	-19.4%
EPS Growth Years	1
FCF Growth	346.55%
FCF Growth Q	-27.73%
OCF Growth	256.1%
OCF Growth Q	-20.42%
OCF Growth3 Y	26.96%
OCF Growth5 Y	30.47%
Revenue Growth	42.69x
Revenue Growth Q	34.67x
Revenue Growth Quarters	6x
Revenue Growth Years	2x
Revenue Growth3 Y	13.2x
Revenue Growth5 Y	15.31x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.4
Assets	CAD 165.3M
Cash	CAD 7M
Current Assets	CAD 22.9M
Current Liabilities	CAD 39M
Debt	CAD 48M
Debt EBITDA	CAD 3.92
Debt Equity	CAD 0.63
Debt FCF	CAD 4.3
Equity	CAD 75.9M
Interest Coverage	-1.55
Liabilities	CAD 89.3M
Long Term Assets	CAD 142.3M
Long Term Liabilities	CAD 50.4M
Net Cash	CAD -41.1M
Net Cash By Market Cap	CAD -50.34
Net Debt EBITDA	CAD 3.35
Net Debt Equity	CAD 0.54
Net Debt FCF	CAD 3.68
Tangible Book Value	CAD -13.5M
Tangible Book Value Per Share	CAD -0.05
WACC	9.08

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.59
Inventory Turnover	4.18
Net Working Capital	CAD -11.5M
Quick ratio	0.27
Working Capital	CAD -16.1M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.77%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	200%
200-day SMA	0.27
3Y total return	11.86%
50-day SMA	0.27
50-day SMA vs 200-day SMA	50over200
5Y total return	-65.98%
All Time High	2.1
All Time High Change	-84.29%
All Time High Date	2019-05-21
All Time Low	0.1
All Time Low Change	230%
All Time Low Date	2025-05-12
ATR	0.02
Beta	0.77
Beta1y	0.8
Beta2y	0.73
Ch YTD	29.41
High	0.34
High52	0.4
High52 Date	2026-04-30
High52ch	-17.5%
Low	0.33
Low52	0.1
Low52 Date	2025-05-15
Low52ch	230%
Ma50ch	23.36%
Price vs 200-day SMA	23.55%
RSI	59.65
RSI Monthly	54.76
RSI Weekly	59.83
Sharpe ratio	1.39x
Sortino ratio	2.38
Total Return	-2.77%
Tr YTD	29.41
Tr1m	26.92%
Tr1w	-4.35%
Tr3m	17.86%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -9.5M
Operating margin	-13.51

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	101,543,148%
Net Borrowing	-7,651,378.9
Shares Insiders	22.13%
Shares Institutions	34.93%
Shares Out	251,033,873
Shares Qo Q	0.03%
Shares Yo Y	2.77%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD 11.1M
Average Volume	30,682.05x
Bv Per Share	0.31
CAPEX	CAD -4.9M
Ch1m	26.92
Ch1w	-4.35
Ch1y	200
Ch3m	17.86
Ch3y	11.86
Ch5y	-65.98
Ch6m	29.41
Change	-2.94%
Change From Open	-1.49
Close	0.34
Days Gap	-1.47
Depreciation Amortization	21,704,652.9
Dollar Volume	1,980
Earnings Date	2026-04-29
EBIT	CAD -9.5M
EBITDA	CAD 12.3M
EPS	CAD -0.1
F Score	4
FCF	CAD 11.2M
FCF EV Yield	9.11x
FCF Per Share	CAD 0.04
Financing CF	-7,674,159
Fiscal Year End	December
Founded	2,015
Goodwill	2,828,426.5
Income Tax	CAD 3.8M
Investing CF	-7,756,426
Is Primary Listing	1
Last Earnings Date	2026-04-29
Last Report Date	2025-12-31
Ma150	0.28
Ma150ch	19.18%
Ma20	0.3
Ma20ch	10.74%
Net CF	627,973
Next Earnings Date	2026-05-20
Open	0.34
P FCF Ratio	7.31
P OCF Ratio	5.08
Position In Range	0
Ppne	52,702,511.6
Price Date	2026-05-08
Price EBITDA	CAD 6.66
Relative Volume	0.19x
Revenue	70,430,321x
SBC By Revenue	0.09x
Share Based Comp	64,443
Tax By Revenue	5.41x
Tr6m	29.41%
Volume	6,000

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CSE/VEXT pay a dividend?

Capital-return profile for this ticker.

Performance

CSE/VEXT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CSE/VEXT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+34.9%

Share of float held by funds and institutions

Insider ownership

+22.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+2.8%

Negative means the company is buying back shares.

Technical

CSE/VEXT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

59.6

Neutral momentum band

Price vs 200-day MA

+23.5%

50/200-day relationship not available

Beta (5Y)

0.77

Less volatile than the market

Sharpe ratio

1.39

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CSE/VEXT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/VEXT stock rating?

cse/VEXT is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/VEXT analysis?

The full report lives at /stocks/cse/VEXT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/VEXT?

The latest report frames cse/VEXT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/VEXT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.